Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

Study testing aging markers and herbal medicine for women with unexplained infertility

Recruiting · BEYOND GENOMiX SA, AG, Ltd

What this means

This trial will check whether blood tests of aging markers can point to causes of long-term infertility. It will also test if a personal plan using these tests can help pregnancy results.

Plain-English summary written by an AI model from the registry listing.

Status
Recruiting
Who can join
Ages 25–42
Where
1 site

Contacts and how to join ↗

The science

Registered title
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility
Phase
Not applicable
Study type
interventional
Conditions
Idiopathic Infertility, Infertility Unexplained, Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Infertility Female
What is tested
1. Aging Hallmarks Biomarker Profiling (Telomere-Based), 2. Integrative Botanical and Nutraceutical Intervention, 3. Natural Conception or Assisted Reproductive Technologies
Sponsor
BEYOND GENOMiX SA, AG, Ltd
Ages
25 Years to 42 Years
Dates
First posted Feb 12, 2026 · updated Apr 29, 2026

Registry summary

The goal of this clinical trial is to determine whether telomere profiling and other biological aging hallmarks can help identify underlying mechanisms of persistent infertility in women with post-treatment unexplained infertility. The study also evaluates whether a personalized integrative treatment guided by these biomarkers can improve reproductive outcomes.

The study includes women aged 25 to 42 years who continue to experience infertility despite appropriate management of identifiable reproductive conditions and repeated attempts with assisted reproductive technologies (ART), such as intrauterine insemination (IUI) or in vitro fertilization (IVF).

The main questions this study aims to answer are:

  • Can telomere and biological aging hallmarks profiling identify a biological aging phenotype associated with infertility?
  • Can an integrative treatment guided by these profiles improve clinical pregnancy outcomes?

Participants will:

  • Undergo a baseline reproductive evaluation and blood-based assessment of telomeres and aging hallmarks.
  • Receive an integrative approach combining Traditional Chinese Medicine (TCM), targeted nutritional support, and standard fertility care.
  • Proceed with natural conception attempts or standard assisted reproductive technologies following the preconception phase.
  • Participants will be followed to assess pregnancy outcomes and changes in biological aging hallmarks.

Sites (1)

  • BEYOND GENOMiX Research and Coordination Center, Neuchâtel, Switzerland
Report a problem